Skip to main content
NVDA-0.19%AAPL+1.11%GOOGL-2.28%MSFT+0.03%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.84%TSLA-0.42%SKHY+7.05%MU-1.35%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.65%0005.HK-0.78%HSBA.L-1.45%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.22%CHFJPY-1.73%USDJPY-1.64%AUDJPY-1.55%EURJPY-1.46%CADJPY-1.44%GBPJPY-1.39%GBPNZD+0.83%NZDCAD-0.80%EURNZD+0.79%AUDNZD+0.70%NZDUSD-0.60%NZDCHF-0.52%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.27%GBPUSD+0.25%GBPZAR+0.22%EURZAR+0.22%EURNOK+0.21%USDZAR+0.21%USDNOK+0.20%NZDSGD+0.19%USDCAD-0.19%AUDCHF+0.19%EURUSD+0.18%NZDMXN+0.17%USDILS+0.16%CHFNOK+0.16%AUDCAD-0.14%GBPAUD+0.14%AUDDKK-0.12%USDTHB+0.12%NOKJPY-0.11%USDTRY+0.11%USDCHF+0.10%EURCZK-0.09%EURAUD+0.09%AUDNOK+0.09%AUDUSD+0.09%EURSEK+0.08%GBPSGD+0.07%EURSGD+0.07%EURPLN+0.07%USDSEK+0.07%USDSGD+0.06%USDPLN+0.06%USDMXN+0.06%AUDSGD-0.05%EURGBP-0.05%USDCOP-0.04%PLNJPY+0.03%USDCNH-0.03%SGDJPY+0.03%GBPCAD+0.03%CHFSEK+0.02%EURCAD-0.02%CHFSGD+0.02%USDHKD+0.01%USDDKK-0.01%EURDKK0.00%EURCNH0.00%EURHKD0.00%COFFEE-2.46%SUGAR+1.85%XPTUSD-1.72%COTTON+1.40%COCOA-1.30%GAGUSD-1.06%XAGUSD-1.04%HG1-0.97%USOIL+0.67%S1+0.53%C1+0.47%UKOIL+0.47%BTCUSD-0.43%ETHUSD0.00%USDTUSD-0.03%XRPUSD-1.28%SOLUSD-0.49%TRXUSDT+0.42%ZECUSDT-1.76%DOGEUSD-1.44%XMRUSDT-0.83%LINKUSD-0.08%XLMUSD-1.08%BCHUSDT-1.93%LTCUSD-1.59%UNIUSD-2.13%TONUSD+24.88%HBARUSDT-1.31%SUIUSD-1.38%TAOUSDT-1.11%AAVEUSD-1.67%DOTUSDT-2.18%ICPUSDT-1.08%ONDOUSDT-2.09%WLDUSDT-1.95%ATOMUSDT-2.11%ARBUSDT-0.27%JUPUSDT-2.96%INJUSDT-2.70%STXUSDT-2.70%FETUSDT-2.39%TIAUSDT-0.87%SEIUSDT-3.91%PYTHUSDT-1.24%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.33%OPUSDT-1.99%POLUSDT-3.22%IOTAUSDT-2.53%AXSUSDT-2.04%FARTCOINUSDT-1.57%EOSUSDT+0.06%DYDXUSDT-0.80%ORDIUSDT+0.59%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.19%AAPL+1.11%GOOGL-2.28%MSFT+0.03%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.84%TSLA-0.42%SKHY+7.05%MU-1.35%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.65%0005.HK-0.78%HSBA.L-1.45%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.22%CHFJPY-1.73%USDJPY-1.64%AUDJPY-1.55%EURJPY-1.46%CADJPY-1.44%GBPJPY-1.39%GBPNZD+0.83%NZDCAD-0.80%EURNZD+0.79%AUDNZD+0.70%NZDUSD-0.60%NZDCHF-0.52%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.27%GBPUSD+0.25%GBPZAR+0.22%EURZAR+0.22%EURNOK+0.21%USDZAR+0.21%USDNOK+0.20%NZDSGD+0.19%USDCAD-0.19%AUDCHF+0.19%EURUSD+0.18%NZDMXN+0.17%USDILS+0.16%CHFNOK+0.16%AUDCAD-0.14%GBPAUD+0.14%AUDDKK-0.12%USDTHB+0.12%NOKJPY-0.11%USDTRY+0.11%USDCHF+0.10%EURCZK-0.09%EURAUD+0.09%AUDNOK+0.09%AUDUSD+0.09%EURSEK+0.08%GBPSGD+0.07%EURSGD+0.07%EURPLN+0.07%USDSEK+0.07%USDSGD+0.06%USDPLN+0.06%USDMXN+0.06%AUDSGD-0.05%EURGBP-0.05%USDCOP-0.04%PLNJPY+0.03%USDCNH-0.03%SGDJPY+0.03%GBPCAD+0.03%CHFSEK+0.02%EURCAD-0.02%CHFSGD+0.02%USDHKD+0.01%USDDKK-0.01%EURDKK0.00%EURCNH0.00%EURHKD0.00%COFFEE-2.46%SUGAR+1.85%XPTUSD-1.72%COTTON+1.40%COCOA-1.30%GAGUSD-1.06%XAGUSD-1.04%HG1-0.97%USOIL+0.67%S1+0.53%C1+0.47%UKOIL+0.47%BTCUSD-0.43%ETHUSD0.00%USDTUSD-0.03%XRPUSD-1.28%SOLUSD-0.49%TRXUSDT+0.42%ZECUSDT-1.76%DOGEUSD-1.44%XMRUSDT-0.83%LINKUSD-0.08%XLMUSD-1.08%BCHUSDT-1.93%LTCUSD-1.59%UNIUSD-2.13%TONUSD+24.88%HBARUSDT-1.31%SUIUSD-1.38%TAOUSDT-1.11%AAVEUSD-1.67%DOTUSDT-2.18%ICPUSDT-1.08%ONDOUSDT-2.09%WLDUSDT-1.95%ATOMUSDT-2.11%ARBUSDT-0.27%JUPUSDT-2.96%INJUSDT-2.70%STXUSDT-2.70%FETUSDT-2.39%TIAUSDT-0.87%SEIUSDT-3.91%PYTHUSDT-1.24%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.33%OPUSDT-1.99%POLUSDT-3.22%IOTAUSDT-2.53%AXSUSDT-2.04%FARTCOINUSDT-1.57%EOSUSDT+0.06%DYDXUSDT-0.80%ORDIUSDT+0.59%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%
NE

NeuroPace, Inc. (NPCE)

NASDAQHealthcare

$14.5
-$0.25 (-1.8%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$14.68
Day Range$14.41 - $14.77
Avg. Volume (3M)139.5K
Market Cap$494.3M
52 Week Range
$9.22$19.6
Next EarningsIn 54 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$22.8M100%
Gross Profitminus cost of goods$18.9M83%

In plain terms: out of every $100 in revenue, NeuroPace, Inc. currently loses $27.

Fundamentals & Financials

Revenue (TTM)
$98.8M
Net Income (TTM)
-$19.1M
EPS (TTM)
-$0.57
ROA (TTM)
-19.71%
Current Ratio
4.94

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+42.9%Q1 2026-$0.08
-5.3%Q2 2026-$0.2
+17.4%Q3 2026-$0.18
Next

Nov 3

in 54 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About NeuroPace, Inc.

NeuroPace, Inc. develops implantable neuromodulation technology for epilepsy care and trades on NASDAQ as NPCE. The healthcare company works in medical devices, centered on the RNS system for drug-resistant focal epilepsy, and generated $100.0 million of revenue in FY2025 across its United States hospital-facility customer base.

Name
NeuroPace, Inc.
CEO
Joel D. Becker
Industry
Healthcare
Year Founded
1997
Employees
220

Today's Snapshot

AI-generated

NPCE closed 1.8% lower at 14.50, while its sector was flat. Shares changed hands at about half of its usual level. NeuroPace outlined its growth plans and route to FDA approval at Cantor, a healthcare investor conference.

Trading Volume

Below 10d avg (130.9K)

74.9K

vs S&P 500 Today

Underperforming Market

-1.34%

Updated: September 9, 2026 at 20:12 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
NPCE is rated Sell with the price near 14.50 and trading below most medium- and long-term averages, including the 200-day, which supports a bearish tilt. Momentum and MACD are muted and oscillators sit near neutral, reflecting limited conviction, while ADX remains low and indicates a lack of strong trend. Volume-based OBV is positive, suggesting some accumulation that contrasts with the moving-average bearishness, and volatility is moderate with ATR around 4.6 percent. The classic pivot near 14.80 is slightly above the market and does not overturn the cautious stance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$14.61 - $15.07
    Sell
  • RSI (14)48.11
    Neutral
  • Stochastic %K (14, 3, 3)58.00
    Neutral
  • MACD Level (12, 26)-0.02
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.